C
Edwards Lifesciences Corporation EW
$81.83 $0.670.83% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 333.20M 358.00M 385.60M 3.07B 366.30M
Total Depreciation and Amortization 38.10M 36.60M 42.60M 34.50M 39.60M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 89.20M 7.90M -92.60M -3.44B -9.40M
Change in Net Operating Assets -170.30M -122.10M -463.10M 683.60M -25.00M
Cash from Operations 290.20M 280.40M -127.50M 351.80M 371.50M
Capital Expenditure -49.30M -56.00M -49.80M -51.90M -85.40M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -298.20M -763.60M --
Divestitures -- -- 0.00 3.93B --
Other Investing Activities -122.80M 141.30M -228.70M -410.20M 210.20M
Cash from Investing -172.10M 85.30M -576.70M 2.70B 124.80M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 101.70M 49.90M 28.60M 34.50M 54.30M
Repurchase of Common Stock -- -308.60M -100.00K -1.00B -158.10M
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -49.00M 700.00K 100.00K -10.20M 7.20M
Cash from Financing 52.70M -258.00M 28.60M -976.70M -96.60M
Foreign Exchange rate Adjustments -29.60M -17.70M 51.00M -51.50M 29.40M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 141.20M 90.00M -624.60M 2.03B 429.10M